Khoja
Khoja v. Orexigen Therapeutics, Inc.
United States District Court, Southern District of CaliforniaNovember 2, 20203:15-cv-00540California10,186 words
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF CALIFORNIA 10 KARIM KHOJA, on behalf of himself and Case No.: 15-CV-540 JLS (JLB) all others similarly situated,
ORDER (1) GRANTING IN PART
Plaintiff, AND DENYING IN PART MOVING v. DEFENDANTS’ REQUEST TO
CONSIDER MATERIALS
OREXIGEN THERAPEUTICS, INC.,
INCORPORATED BY REFERENCE,
JOSEPH P. HAGAN, MICHAEL A.
AND (2) GRANTING MOVING
NARACHI, and PRESTON KLASSEN,
DEFENDANTS’ PARTIAL MOTION
Defendants. TO DISMISS
18 AND ALL CONSOLIDATED CASES (ECF No. 114)
Presently before the Court is Moving Defendants Joseph P. Hagan, Michael A. Narachi, and Preston Klassen, M.D., M.H.S.’s Partial Motion to Dismiss Consolidated Amended Complaint for Violation of the Federal Securities Laws (“Mot.,” ECF No. 114),1 as well as Lead Plaintiff Karim Khoja’s Opposition to (“Opp’n,” ECF No. 115) and Moving Defendants’ Reply in Support of (“Reply,” ECF No. 116) the Motion.
26 1 Defendant…